Clover Health Investments Corp.
03/06/2026 | Press release | Distributed by Public on 03/06/2026 07:46
Regulation FD Disclosure (Form 8-K)
Item 7.01. Regulation FD Disclosure.
On March 6, 2026, Clover Health Investments, Corp. (the "Company") published a list of responses to a selection of frequently asked supplemental questions submitted in connection with the Company's fourth quarter 2025 earnings announcement in order to further engagement with the Company's shareholder base. The supplemental questions and the Company's accompanying written responses are furnished as Exhibit 99.1 to this Current Report on Form 8-K, and are also available on the investor relations section of the Company's website.
The information set forth in this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed to be incorporated by reference into any filing made under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Clover Health Investments Corp. published this content on March 06, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 06, 2026 at 13:46 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]